FDA Authorizes New Over-the-Counter Naloxone Nasal Spray

The FDA has granted approval for Rextovy, an additional naloxone nasal spray, to be sold without a prescription. This decision expands consumer access to emergency treatment for opioid overdoses. The aim is to offer more options for rapidly reversing overdose effects.